Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. BAC

Go back to Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer
Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 54.97 -0.25 (0.45%)
Previous Close $55.22    52 Week High $35.13 
Open $54.55    52 Week Low $28.10 
Day High $55.20    P/E N/A 
Day Low $54.43    EPS $0.00 
Volume 863,861       

Brown & Brown, Inc. (NYSE: RO) Delayed: 8.49 +0.55 (6.93%)
Previous Close $7.94    52 Week High $8.59 
Open $7.94    52 Week Low $7.82 
Day High $8.59    P/E 6.53 
Day Low $7.82    EPS $1.30 
Volume 42,732       

Roper Industries (NASDAQ: ROP) Delayed: 407.28 -15.07 (3.57%)
Previous Close $422.35    52 Week High $195.93 
Open $418.41    52 Week Low $155.79 
Day High $419.21    P/E 75.84 
Day Low $405.57    EPS $5.37 
Volume 616,800